Study Results
Results pending
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
Recruitment Status
UNKNOWN
Total Enrollment
30 participants
Study Classification
OBSERVATIONAL
Study Start Date
2017-03-01
Study Completion Date
2019-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study is designed to determine if a simplified technique for cardiac device reprogramming using pulmonary artery pressure (PAP) data in the acute setting holds promise to improve subjective assessments of patient quality of life (QOL), objective measurements of functional capacity, and specific systolic and diastolic echocardiographic indices.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigation to Optimize Hemodynamic Management of Left Ventricular Assist Devices Using the CardioMEMS™
NCT03247829
Heart Failure
COMPLETED
CardioMEMS HF System Real-World Evidence Post-Approval Study
NCT06306573
Heart Failure NYHA Class II
Heart Failure NYHA Class III
ENROLLING_BY_INVITATION
REmodeling the Left Ventricle With Atrial Modulated Pacing
NCT03210402
Heart Failure
COMPLETED
NA
CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in NYHA Class III Heart Failure Patients
NCT00531661
Heart Failure, Congestive
COMPLETED
NA
Efficacy Study of Pacemakers to Treat Slow Heart Rate in Patients With Heart Failure
NCT02145351
Heart Failure With a Preserved Ejection Fraction
Heart Failure, Diastolic
Chronotropic Incompetence
COMPLETED
NA
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The present study is designed to determine if a simplified technique for cardiac device( CRT) reprogramming using pulmonary artery pressure (PAP) via implanted CardioMEMS device data in the acute setting holds promise to improve subjective assessments of patient quality of life (QOL), objective measurements of functional capacity, and specific systolic and diastolic echocardiographic indices. The protocol requires prospective collection and analysis of echocardiographic data, subjective symptoms (Minnesota Living with Heart Failure Questionnaires), and 6-minute walk distance measurements in patients with implanted biventricular pacemakers / defibrillators who are predominantly ventricularly paced, in normal sinus rhythm, have documented NYHA class 3 Heart Failure, and have implanted pulmonary artery pressure monitors (CardioMEMS, St. Jude Medical CRMD, St. Paul, MN). Data collection will occur at presentation (rest and with ambulation), one month post-reprogramming, and two months after evaluation and / or reprogramming.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Heart Failure
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
Observational Model Type
CASE_CROSSOVER
Study Time Perspective
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A-Active reprogram follwed by sham
This arm will be randomized to have PACING device reprogramming followed by sham reprogramming
Active reprogam
Intervention Type
DEVICE
Reprogram Changes in AV/PV delays
B-Sham followed by active reprogram
This arm will be randomized to have sham reprogramming followed by active pacing reprogramming
Active reprogam
Intervention Type
DEVICE
Reprogram Changes in AV/PV delays
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Active reprogam
Reprogram Changes in AV/PV delays
Intervention Type
DEVICE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Patients have implanted PPM, ICD, or CRT devices and CardioMEMS
2. Patients can ambulate for 6 minutes and lay on a flat surface
3. Patients are paced \> 95% of the time
4. Patients are not in acute CHF and are on a stable medication regimen
5. Patients have adequate echocardiographic windows
6. Patients can consent independently
2. Patients can ambulate for 6 minutes and lay on a flat surface
3. Patients are paced \> 95% of the time
4. Patients are not in acute CHF and are on a stable medication regimen
5. Patients have adequate echocardiographic windows
6. Patients can consent independently
Exclusion Criteria
1. Patients with poor echocardiographic acoustical resolution.
2. Patients with congenital heart disease.
3. Patients with mechanical aortic or mitral valve replacements.
4. Patients with significant mitral annular calcification.
5. Patients with irregular heart rates: atrial fibrillation, supraventricular tachycardia, atrial premature contractions, and ventricular arrhythmia that would preclude data acquisition.
6. Patients unable to remain still secondary to movement disorders or agitation.
7. Inpatient status
8. Patients with poorly controlled HTN (SBP\>160/90
2. Patients with congenital heart disease.
3. Patients with mechanical aortic or mitral valve replacements.
4. Patients with significant mitral annular calcification.
5. Patients with irregular heart rates: atrial fibrillation, supraventricular tachycardia, atrial premature contractions, and ventricular arrhythmia that would preclude data acquisition.
6. Patients unable to remain still secondary to movement disorders or agitation.
7. Inpatient status
8. Patients with poorly controlled HTN (SBP\>160/90
Eligible Sex
ALL
Accepts Healthy Volunteers
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
St. Francis Hospital, New York
OTHER
Sponsor Role
lead
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rita Jermyn, MD
Director of Center for Cardiac Therapeutics
Responsibility Role
PRINCIPAL_INVESTIGATOR
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rita Jermyn, MD
Role: PRINCIPAL_INVESTIGATOR
Saint Francis Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St Francis Hospital
Roslyn, New York, United States
Site Status
RECRUITING
Countries
Review the countries where the study has at least one active or historical site.
United States
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, Packer M, Clavell AL, Hayes DL, Ellestad M, Trupp RJ, Underwood J, Pickering F, Truex C, McAtee P, Messenger J; MIRACLE Study Group. Multicenter InSync Randomized Clinical Evaluation. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002 Jun 13;346(24):1845-53. doi: 10.1056/NEJMoa013168.
Reference Type
RESULT
Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, Canby RC, Schroeder JS, Liem LB, Hall S, Wheelan K; Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA. 2003 May 28;289(20):2685-94. doi: 10.1001/jama.289.20.2685.
Reference Type
RESULT
Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J, Abraham WT, Ghio S, Leclercq C, Bax JJ, Yu CM, Gorcsan J 3rd, St John Sutton M, De Sutter J, Murillo J. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation. 2008 May 20;117(20):2608-16. doi: 10.1161/CIRCULATIONAHA.107.743120. Epub 2008 May 5.
Reference Type
RESULT
Mullens W, Grimm RA, Verga T, Dresing T, Starling RC, Wilkoff BL, Tang WH. Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program. J Am Coll Cardiol. 2009 Mar 3;53(9):765-73. doi: 10.1016/j.jacc.2008.11.024.
Reference Type
RESULT
Birnie D, Lemke B, Aonuma K, Krum H, Lee KL, Gasparini M, Starling RC, Milasinovic G, Gorcsan J 3rd, Houmsse M, Abeyratne A, Sambelashvili A, Martin DO. Clinical outcomes with synchronized left ventricular pacing: analysis of the adaptive CRT trial. Heart Rhythm. 2013 Sep;10(9):1368-74. doi: 10.1016/j.hrthm.2013.07.007. Epub 2013 Jul 11.
Reference Type
RESULT
Martin DO, Lemke B, Birnie D, Krum H, Lee KL, Aonuma K, Gasparini M, Starling RC, Milasinovic G, Rogers T, Sambelashvili A, Gorcsan J 3rd, Houmsse M; Adaptive CRT Study Investigators. Investigation of a novel algorithm for synchronized left-ventricular pacing and ambulatory optimization of cardiac resynchronization therapy: results of the adaptive CRT trial. Heart Rhythm. 2012 Nov;9(11):1807-14. doi: 10.1016/j.hrthm.2012.07.009. Epub 2012 Jul 14.
Reference Type
RESULT
Starling RC, Krum H, Bril S, Tsintzos SI, Rogers T, Hudnall JH, Martin DO. Impact of a Novel Adaptive Optimization Algorithm on 30-Day Readmissions: Evidence From the Adaptive CRT Trial. JACC Heart Fail. 2015 Jul;3(7):565-572. doi: 10.1016/j.jchf.2015.03.001. Epub 2015 Jun 10.
Reference Type
RESULT
Galderisi M, Benjamin EJ, Evans JC, D'Agostino RB, Fuller DL, Lehman B, Wolf PA, Levy D. Intra- and interobserver reproducibility of Doppler-assessed indexes of left ventricular diastolic function in a population-based study (the Framingham Heart Study). Am J Cardiol. 1992 Nov 15;70(15):1341-6. doi: 10.1016/0002-9149(92)90772-q.
Reference Type
RESULT
Ritter P, Padeletti L, Gillio-Meina L, Gaggini G. Determination of the optimal atrioventricular delay in DDD pacing. Comparison between echo and peak endocardial acceleration measurements. Europace. 1999 Apr;1(2):126-30. doi: 10.1053/eupc.1998.0032.
Reference Type
RESULT
Meluzin J, Novak M, Mullerova J, Krejci J, Hude P, Eisenberger M, Dusek L, Dvorak I, Spinarova L. A fast and simple echocardiographic method of determination of the optimal atrioventricular delay in patients after biventricular stimulation. Pacing Clin Electrophysiol. 2004 Jan;27(1):58-64. doi: 10.1111/j.1540-8159.2004.00386.x.
Reference Type
RESULT
Kindermann M, Frohlig G, Doerr T, Schieffer H. Optimizing the AV delay in DDD pacemaker patients with high degree AV block: mitral valve Doppler versus impedance cardiography. Pacing Clin Electrophysiol. 1997 Oct;20(10 Pt 1):2453-62. doi: 10.1111/j.1540-8159.1997.tb06085.x.
Reference Type
RESULT
Sawhney NS, Waggoner AD, Garhwal S, Chawla MK, Osborn J, Faddis MN. Randomized prospective trial of atrioventricular delay programming for cardiac resynchronization therapy. Heart Rhythm. 2004 Nov;1(5):562-7. doi: 10.1016/j.hrthm.2004.07.006.
Reference Type
RESULT
Butter C, Stellbrink C, Belalcazar A, Villalta D, Schlegl M, Sinha A, Cuesta F, Reister C. Cardiac resynchronization therapy optimization by finger plethysmography. Heart Rhythm. 2004 Nov;1(5):568-75. doi: 10.1016/j.hrthm.2004.07.002.
Reference Type
RESULT
Perego GB, Chianca R, Facchini M, Frattola A, Balla E, Zucchi S, Cavaglia S, Vicini I, Negretto M, Osculati G. Simultaneous vs. sequential biventricular pacing in dilated cardiomyopathy: an acute hemodynamic study. Eur J Heart Fail. 2003 Jun;5(3):305-13. doi: 10.1016/s1388-9842(02)00204-0.
Reference Type
RESULT
van Gelder BM, Bracke FA, Meijer A, Lakerveld LJ, Pijls NH. Effect of optimizing the VV interval on left ventricular contractility in cardiac resynchronization therapy. Am J Cardiol. 2004 Jun 15;93(12):1500-3. doi: 10.1016/j.amjcard.2004.02.061.
Reference Type
RESULT
Yu CM, Fung JW, Zhang Q, Chan CK, Chan YS, Lin H, Kum LC, Kong SL, Zhang Y, Sanderson JE. Tissue Doppler imaging is superior to strain rate imaging and postsystolic shortening on the prediction of reverse remodeling in both ischemic and nonischemic heart failure after cardiac resynchronization therapy. Circulation. 2004 Jul 6;110(1):66-73. doi: 10.1161/01.CIR.0000133276.45198.A5. Epub 2004 Jun 14.
Reference Type
RESULT
Lee KL, Burnes JE, Mullen TJ, Hettrick DA, Tse HF, Lau CP. Avoidance of right ventricular pacing in cardiac resynchronization therapy improves right ventricular hemodynamics in heart failure patients. J Cardiovasc Electrophysiol. 2007 May;18(5):497-504. doi: 10.1111/j.1540-8167.2007.00788.x. Epub 2007 Apr 11.
Reference Type
RESULT
van Gelder BM, Bracke FA, Meijer A, Pijls NH. The hemodynamic effect of intrinsic conduction during left ventricular pacing as compared to biventricular pacing. J Am Coll Cardiol. 2005 Dec 20;46(12):2305-10. doi: 10.1016/j.jacc.2005.02.098.
Reference Type
RESULT
Thibault B, Ducharme A, Harel F, White M, O'Meara E, Guertin MC, Lavoie J, Frasure-Smith N, Dubuc M, Guerra P, Macle L, Rivard L, Roy D, Talajic M, Khairy P; Evaluation of Resynchronization Therapy for Heart Failure (GREATER-EARTH) Investigators. Left ventricular versus simultaneous biventricular pacing in patients with heart failure and a QRS complex >/=120 milliseconds. Circulation. 2011 Dec 20;124(25):2874-81. doi: 10.1161/CIRCULATIONAHA.111.032904. Epub 2011 Nov 21.
Reference Type
RESULT
Yu CM, Wang L, Chau E, Chan RH, Kong SL, Tang MO, Christensen J, Stadler RW, Lau CP. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation. 2005 Aug 9;112(6):841-8. doi: 10.1161/CIRCULATIONAHA.104.492207. Epub 2005 Aug 1.
Reference Type
RESULT
Khoury DS, Naware M, Siou J, Blomqvist A, Mathuria NS, Wang J, Shih HT, Nagueh SF, Panescu D. Ambulatory monitoring of congestive heart failure by multiple bioelectric impedance vectors. J Am Coll Cardiol. 2009 Mar 24;53(12):1075-81. doi: 10.1016/j.jacc.2008.12.018.
Reference Type
RESULT
Maines M, Catanzariti D, Cemin C, Vaccarini C, Vergara G. Usefulness of intrathoracic fluids accumulation monitoring with an implantable biventricular defibrillator in reducing hospitalizations in patients with heart failure: a case-control study. J Interv Card Electrophysiol. 2007 Sep;19(3):201-7. doi: 10.1007/s10840-007-9155-4. Epub 2007 Sep 6.
Reference Type
RESULT
Small RS, Wickemeyer W, Germany R, Hoppe B, Andrulli J, Brady PA, Labeau M, Koehler J, Sarkar S, Hettrick DA, Tang WH. Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert. J Card Fail. 2009 Aug;15(6):475-81. doi: 10.1016/j.cardfail.2009.01.012. Epub 2009 Mar 17.
Reference Type
RESULT
Sogaard P, Egeblad H, Pedersen AK, Kim WY, Kristensen BO, Hansen PS, Mortensen PT. Sequential versus simultaneous biventricular resynchronization for severe heart failure: evaluation by tissue Doppler imaging. Circulation. 2002 Oct 15;106(16):2078-84. doi: 10.1161/01.cir.0000034512.90874.8e.
Reference Type
RESULT
Sogaard P, Egeblad H, Kim WY, Jensen HK, Pedersen AK, Kristensen BO, Mortensen PT. Tissue Doppler imaging predicts improved systolic performance and reversed left ventricular remodeling during long-term cardiac resynchronization therapy. J Am Coll Cardiol. 2002 Aug 21;40(4):723-30. doi: 10.1016/s0735-1097(02)02010-7.
Reference Type
RESULT
Haugaa KH, Marek JJ, Ahmed M, Ryo K, Adelstein EC, Schwartzman D, Saba S, Gorcsan J 3rd. Mechanical dyssynchrony after cardiac resynchronization therapy for severely symptomatic heart failure is associated with risk for ventricular arrhythmias. J Am Soc Echocardiogr. 2014 Aug;27(8):872-9. doi: 10.1016/j.echo.2014.04.001. Epub 2014 May 3.
Reference Type
RESULT
Papadopoulou E, Kaladaridou A, Mattheou J, Pamboucas C, Hatzidou S, Antoniou A, Toumanidis S. Effect of pacing mode and pacing site on torsional and strain parameters and on coronary flow. J Am Soc Echocardiogr. 2015 Mar;28(3):347-54. doi: 10.1016/j.echo.2014.10.014. Epub 2014 Nov 26.
Reference Type
RESULT
Abraham WT, Adamson PB, Bourge RC, Aaron MF, Costanzo MR, Stevenson LW, Strickland W, Neelagaru S, Raval N, Krueger S, Weiner S, Shavelle D, Jeffries B, Yadav JS; CHAMPION Trial Study Group. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet. 2011 Feb 19;377(9766):658-66. doi: 10.1016/S0140-6736(11)60101-3.
Reference Type
RESULT
Pappone C, Augello G, Rosanio S, Vicedomini G, Santinelli V, Romano M, Agricola E, Maggi F, Buchmayr G, Moretti G, Mika Y, Ben-Haim SA, Wolzt M, Stix G, Schmidinger H. First human chronic experience with cardiac contractility modulation by nonexcitatory electrical currents for treating systolic heart failure: mid-term safety and efficacy results from a multicenter study. J Cardiovasc Electrophysiol. 2004 Apr;15(4):418-27. doi: 10.1046/j.1540-8167.2004.03580.x.
Reference Type
RESULT
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17-13
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.
Optimal Anti-tachycardia Therapy in Implantable Cardioverter-defibrillator (ICD) Patients Without Pacing Indications
NCT00729703
COMPLETED
PHASE4
Validation of CardioMEMS HF System Cardiac Output Algorithm IDE
NCT05428384
COMPLETED
TARGET-LOAD Pilot Study Comparing Hemodynamics-guided LVAD Unloading Vs. Standard of Care
NCT04977310
WITHDRAWN
NA
Cardiovascular and Neurohormonal Effects of Faster Atrial Pacing Rate
NCT00698139
TERMINATED
NA
Optimal Pacing Rate for Cardiac Resynchronization Therapy
NCT06445439
RECRUITING
NA
Reprogramming to Prevent Progressive Pacemaker-induced Remodelling
NCT03627585
COMPLETED
NA
Cardiac Resynchronisation Therapy Versus Rate-responsive Pacing in Heart Failure With Preserved Ejection Fraction
NCT03338374
COMPLETED
NA
CardioMEMS HF System OUS Post Market Study
NCT02954341
COMPLETED
CardioMEMS HF System Coverage with Evidence Development Study
NCT06779552
RECRUITING
PROSPECT: Predictors of Response to Cardiac Re-Synchronization Therapy
NCT00253357
COMPLETED
Compare Remote Patient Management and Standard Care in CRT-D and ICD-patients to Assess the Effect on Heart Failure
NCT00730548
COMPLETED
NA
Arrythmia Burden in Cardiac Contractility Modulation (CCM)
NCT05704426
TERMINATED
Physiologic Cardiac Pacing to Prevent Left Ventricular Dysfunction Post TAVI
NCT05966675
RECRUITING
NA
Physiologic Accelerated Pacing as a Treatment in Patients With Heart Failure With Preserved Ejection Fraction
NCT04546555
COMPLETED
NA
RethinQ Study - Evaluating Pacing in Heart Failure Patients
NCT00132977
COMPLETED
PHASE3
Cardiac Resynchronization in the Elderly
NCT03031847
COMPLETED
NA
InterventiOn of Biventricular Pacemaker Function on ventrIcular Function Among Patients With LVAD's
NCT03232736
COMPLETED
Registry of Patients With CardioMEMS
NCT02729922
COMPLETED
ECG Optimization of CRT: Evaluation of Mid-term Response
NCT01439529
COMPLETED
PHASE3
Reprieve Cardiovascular System for the Treatment of Subjects With Acute Decompensated Heart Failure Mechanistic Study
NCT05015764
COMPLETED
NA
More Options Available With a Quadripolar LV Lead pRovidE In-clinic Solutions to CRT Challenges
NCT01510652
COMPLETED
NA
Acute Feedback on Left ventrIcular Lead Implantation Location for Cardiac Resynchronization Therapy
NCT01996397
COMPLETED
NA
Assessment of Primary Prevention Patients Receiving An ICD - Systematic Evaluation of ATP
NCT02923726
COMPLETED
NA
CardioMEMS HF System Post Approval Study
NCT02279888
COMPLETED
REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE)
NCT00271154
COMPLETED
NA